2014
DOI: 10.2131/jts.39.765
|View full text |Cite
|
Sign up to set email alerts
|

Cisplatin (CDDP) triggers cell death of MCF-7 cells following disruption of intracellular calcium ([Ca<sup>2+</sup>]<sub>i</sub>) homeostasis

Abstract: -Breast cancer (BC) is a public health problem all over the world. Cisplatin (CDDP) is an antineoplastic agent with high rate of success in treating cancers. The down side of CDDP treatment is the development of chemo-resistance. Beside DNA damage and activation of p53 signaling pathway, CDDP induces tumor-cell death due to elevation in the intracellular calcium concentration ([Ca 2+ ] i ] i elevation significantly (46.6% increase; n = 26) as well as when a pre-application of Caffeine, Ionomycin or Thapsigar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
27
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(28 citation statements)
references
References 28 publications
(38 reference statements)
1
27
0
Order By: Relevance
“…The MTS colorimetric assay was used to determine cytotoxic effects of CLO extract at final concentrations of 50–1000 μg/ml. After 72 hrs of incubation, 10 μl of MTS (Promega, Madison, WI, USA) was added to each well according to the CellTiter 96 ® AQueous One Solution Cell Proliferation Assay protocol.…”
Section: Methodsmentioning
confidence: 99%
“…The MTS colorimetric assay was used to determine cytotoxic effects of CLO extract at final concentrations of 50–1000 μg/ml. After 72 hrs of incubation, 10 μl of MTS (Promega, Madison, WI, USA) was added to each well according to the CellTiter 96 ® AQueous One Solution Cell Proliferation Assay protocol.…”
Section: Methodsmentioning
confidence: 99%
“…Cancer cells might become resistant to these Pt (II) drugs due to detoxification, decreased cellular uptake, DNA repair, increased drug efflux and diminished apoptosis. Platinum (IV) prodrugs are considered one of the approaches developed to overcome the drawbacks of the Pt (II) drugs . The octahedral Pt (IV) complexes are activated by reduction inside the cell to the active platinum (II) counterparts before binding to their target DNA (Figure ) .…”
Section: Introductionmentioning
confidence: 99%
“…Platinum (IV) prodrugs are considered one of the approaches developed to overcome the drawbacks of the Pt (II) drugs. [14][15][16][17][18] The octahedral Pt (IV) complexes are activated by reduction inside the cell to the active platinum (II) counterparts before binding to their target DNA ( Figure 2). [19][20][21][22] The axial ligands in Pt (IV) complexes that are released upon reduction can be used to control important properties of the drug, such as stability, reduction potential and lipophilicity.…”
Section: Introductionmentioning
confidence: 99%
“…Although molecular-targeted cancer therapy has advanced considerably, chemotherapy is the primary treatment for lung cancer cases that are unresectable. For patients with advanced NSCLC, the platinum-based two-drug combination regimen is a standard chemotherapy (3,4). Cisplatin (CDDP)-based chemotherapy has improved the survival rate of patients with NSCLC.…”
Section: Introductionmentioning
confidence: 99%